Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

M3554

😃Good
Catalog No. T209511

M3554 is an innovative anti-GD2 ADC derived from the humanized ch14.18 anti-GD2 antibody, exhibiting antitumor properties. It demonstrates sub-nanomolar IC50 cytotoxicity against GD2-positive neuroblastoma cell line CHP134.

M3554

M3554

😃Good
Catalog No. T209511
M3554 is an innovative anti-GD2 ADC derived from the humanized ch14.18 anti-GD2 antibody, exhibiting antitumor properties. It demonstrates sub-nanomolar IC50 cytotoxicity against GD2-positive neuroblastoma cell line CHP134.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
M3554 is an innovative anti-GD2 ADC derived from the humanized ch14.18 anti-GD2 antibody, exhibiting antitumor properties. It demonstrates sub-nanomolar IC50 cytotoxicity against GD2-positive neuroblastoma cell line CHP134.
Chemical Properties
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy M3554 | purchase M3554 | M3554 cost | order M3554